{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:01:12Z","timestamp":1780336872012,"version":"3.54.1"},"reference-count":29,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Purpose Uric acid serves as a marker for cardiovascular risk and is often linked to inflammation and oxidative stress. There is evidence suggesting an association between uric acid and atrial fibrillation (AF), including its severity and occurrence of crises, as well as its involvement in cardiovascular mechanisms. The objective of this study was to assess the correlation between hyperuricemia and echocardiographic features in patients with chronic AF lasting for more than 5 years. Methods This case-control study involved 107 patients diagnosed with chronic non-valvular AF. Uric acid levels were measured in all patients, and they were divided into two groups: the first group consisted of 66 patients with hyperuricemia (&gt;7.2 mg\/dL), while the second group included 41 patients with normal uric acid levels. Echocardiography (TTE) was performed to evaluate each patient. Various clinical and echocardiographic parameters, such as left ventricle telediastolic (LVTDD) and telesystolic (LVTSD) diameters, left atrial diameter (LAD), aortic diameter (AoD), ejection fraction (EF), and pulmonary artery pressure (PAP), were analyzed. Results Binary logistic regression analysis revealed a statistically significant relationship between uric acid levels (&gt;7.2 mg\/dL) and LAD. For each unit increase in LAD, the probability of having hyperuricemia increased by 9% [odds ratio (OD): 0.91, 95% confidence interval (CI): 0.84\u20140.99]. A significant relationship was found between uric acid levels (&gt;8 mg\/dL) and LVESD (p = 0.045) as well as PAP (p = 0.006). For every unit increase in LVESD, the likelihood of having uric acid levels greater than 8 mg\/dL increased by 22% [OD: 0.82, 95% CI: 0.67\u20140.99, b = \u22120.2]. Likewise, for each unit increase in PAP, the probability of having uric acid levels greater than 8 mg\/dL was 9.4% [OD: 0.91, 95% CI: 0.86\u20140.97, b = \u22120.09]. Conclusions This study demonstrates that hyperuricemia has a significant relationship with the development of atrial remodeling, with an important association observed between hyperuricemia and an increase in left atrial diameter. Hyperuricemia is also correlated with an enlargement of the left ventricle end-systolic diameter and pulmonary artery pressure, showing a possible influence that hyperuricemia might have also left ventricle morphology and right ventricle function.<\/jats:p>","DOI":"10.3390\/jcm12155034","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T10:00:15Z","timestamp":1690797615000},"page":"5034","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Relationship between Hyperuricemia and Echocardiographic Parameters in Patients with Chronic Atrial Fibrillation"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1605-9897","authenticated-orcid":false,"given":"Mikel","family":"Jordhani","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Kor\u00e7a Regional Hospital, 7001 Kor\u00e7a, Albania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majlinda","family":"Cafka","sequence":"additional","affiliation":[{"name":"Cardiovascular Diseases Department, UHC \u201cMother Teresa\u201d, 1000 Tirana, Albania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Seiti","sequence":"additional","affiliation":[{"name":"Cardiovascular Diseases Department, UHC \u201cMother Teresa\u201d, 1000 Tirana, Albania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-7685","authenticated-orcid":false,"given":"Vivencio","family":"Barrios","sequence":"additional","affiliation":[{"name":"Adult Cardiology Department, University Hospital Ramon y Cajal, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"ref_1","first-page":"14","article-title":"Acute treatment of Atrial fibrillation in the emergency department","volume":"13","author":"Martin","year":"2013","journal-title":"Rev. Esp. De Cardiol. Supl."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation:a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: Epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.119.13643","article-title":"Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years","volume":"75","author":"Virdis","year":"2020","journal-title":"Hypertension"},{"key":"ref_7","unstructured":"Mann, D.L., Zipes, D.P., Libby, P., Bonow, R.O., and Braunwald, E. (2015). Braunwald\u2019s Heart Disease, A Textbook of Cardiovascular Medicine, Elsevier Saunders."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1253\/circj.CJ-15-0138","article-title":"Role of inflammation in atrial fibrillation pathophysiology and management","volume":"79","author":"Harada","year":"2015","journal-title":"Circ. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/03007995.2017.1372157","article-title":"Uric acid and incident chronic kidney disease in dyslipidemic individuals","volume":"34","author":"Barkas","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ronco, C., and Rodeghiero, F. (2005). Hyperuricemic Syndromes: Pathophysiology and Therapy, Karger Medical and Scientific Publishers.","DOI":"10.1159\/isbn.978-3-318-01169-2"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40885-020-00146-y","article-title":"Uric acid and cardiometabolic diseases","volume":"26","author":"Lee","year":"2020","journal-title":"Clin. Hypertens."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e027089","DOI":"10.1161\/JAHA.122.027089","article-title":"Elevated Uric Acid Is Associated with New-Onset Atrial Fibrillation: Results from the Swedish AMORIS Cohort","volume":"12","author":"Ding","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2006.04.026","article-title":"The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation","volume":"115","author":"Korantzopoulos","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chiu, T.H., Wu, P.Y., Huang, J.C., Su, H.M., Chen, S.C., Chang, J.M., and Chen, H.C. (2020). Hyperuricemia Is Associated with Left Ventricular Dysfunction and Inappropriate Left Ventricular Mass in Chronic Kidney Disease. Diagnostics, 10.","DOI":"10.3390\/diagnostics10080514"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jacc.2003.11.062","article-title":"Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation","volume":"43","author":"Conway","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.14503\/THIJ-13-3466","article-title":"Inflammation and C-reactive protein in atrial fibrillation: Cause or effect?","volume":"41","author":"Galea","year":"2014","journal-title":"Tex. Heart Inst. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fphys.2012.00150","article-title":"Xanthine oxidase and uric acid in atrial fibrillation","volume":"3","author":"Korantzopoulos","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e000712","DOI":"10.1136\/rmdopen-2018-000712","article-title":"Gout and the risk of incident atrial fibrillation in older adults: A study of US Medicare data","volume":"4","author":"Singh","year":"2018","journal-title":"RMD Open"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.105.538108","article-title":"Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: Role of the NADPH and xanthine oxidases","volume":"112","author":"Dudley","year":"2005","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric Acid and Survival in Chronic Heart Failure","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E663","DOI":"10.1016\/S0735-1097(12)60664-0","article-title":"Hiperuricemia is an independent risk factor of atrial fibrillation due to electrical remodelling through activation of uric acid transporter","volume":"59","author":"Kuwabara","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.99.13368299","article-title":"Hyperuricemia in patients with right or left heart failure","volume":"13","author":"Hoeper","year":"1999","journal-title":"Eur. Respir. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ajh\/hpw159","article-title":"Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population","volume":"30","author":"Cuspidi","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/14397595.2018.1537555","article-title":"Association of hyperuricemia and pulmonary hypertension: A systematic review and meta-analysis","volume":"29","author":"Park","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int."},{"key":"ref_27","first-page":"e37","article-title":"Relationship between serum uric acid levels and ventricular function in patients with idiopathic pulmonary hypertension","volume":"18","author":"Zhang","year":"2013","journal-title":"Exp. Clin. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/heartjnl-2012-302249","article-title":"Allopurinol: Novel indications in cardiovascular disease","volume":"98","author":"Struthers","year":"2012","journal-title":"Heart"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CRD.0b013e318229a908","article-title":"Allopurinol as a cardiovascular drug","volume":"19","author":"Kelkar","year":"2011","journal-title":"Cardiol. Rev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/15\/5034\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:23:05Z","timestamp":1760127785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/15\/5034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":29,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["jcm12155034"],"URL":"https:\/\/doi.org\/10.3390\/jcm12155034","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]}}}